Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Globant
GLOB
$1.71B
| $2.14M | 0.01% |
32,716
+5,617
| +21% | +$353K |
|
852
Avista
AVA
$3.18B
| $2.11M | 0.01% |
54,761
+12,909
| +31% | +$504K |
|
853
Albemarle
ALB
$16.7B
| $2.1M | 0.01% |
14,842
-132,792
| -90% | -$15.1M |
|
|
LWAC
854
LightWave Acquisition Corp
LWAC
$311M
| $2.1M | 0.01% |
208,854
-41,146
| -16% | -$413K |
|
|
OYSE
855
Oyster Enterprises II Acquisition Corp
OYSE
$352M
| $2.08M | 0.01% |
206,491
+56,818
| +38% | +$573K |
|
856
e.l.f. Beauty
ELF
$6.25B
| $2.07M | 0.01% |
27,276
+25,592
| +1,520% | +$2.52M |
|
857
BGC Group
BGC
$5.68B
| $2.07M | 0.01% |
231,799
+36,065
| +18% | +$325K |
|
|
XZO
858
Exzeo Group
XZO
$1.57B
| $2.06M | 0.01% |
+85,083
| New | +$1.62M |
|
859
Seaboard Corp
SEB
$4.05B
| $2.06M | 0.01% |
464
+395
| +572% | +$1.56M |
|
860
Medtronic
MDT
$119B
| $2.06M | 0.01% |
21,469
-146,689
| -87% | -$14.2M |
|
861
Cenovus Energy
CVE
$59.3B
| $2.05M | 0.01% |
+121,259
| New | +$2.11M |
|
|
CCAQ
862
Collective Acquisition Corp
CCAQ
| $2.04M | 0.01% |
200,000
-49,700
| -20% | -$506K |
|
863
Shake Shack
SHAK
$3.05B
| $2.03M | 0.01% |
25,050
+9,691
| +63% | +$854K |
|
|
SBXE.U
864
SilverBox Corp V Units
SBXE.U
| $2.03M | 0.01% |
+201,909
| New | +$2.04M |
|
|
BOW
865
Bowhead Specialty Holdings
BOW
$1.11B
| $2.02M | 0.01% |
70,926
+11,640
| +20% | +$309K |
|
|
TVAI
866
Thayer Ventures Acquisition Corporation II
TVAI
$282M
| $2.02M | 0.01% |
200,000
-20,563
| -9% | -$207K |
|
|
PXED
867
Phoenix Education Partners
PXED
$1.01B
| $2.02M | 0.01% |
+66,751
| New | +$2.24M |
|
868
BellRing Brands
BRBR
$1.26B
| $2.02M | 0.01% |
75,458
+47,632
| +171% | +$1.48M |
|
|
VACI.U
869
Viking Acquisition Corp I Units
VACI.U
| $2.02M | 0.01% |
+200,000
| New | +$2.02M |
|
870
Gerdau
GGB
$8.5B
| $2.01M | 0.01% |
545,963
-734,146
| -57% | -$2.57M |
|
871
KBR
KBR
$4.75B
| $2M | 0.01% |
49,870
-79,398
| -61% | -$3.4M |
|
872
Stoke Therapeutics
STOK
$2.09B
| $2M | 0.01% |
63,109
-174,906
| -73% | -$5.26M |
|
873
Smith & Nephew
SNN
$12.4B
| $2M | 0.01% |
61,042
+14,989
| +33% | +$513K |
|
874
iRhythm Holdings
IRTC
$4.13B
| $2M | 0.01% |
11,258
+471
| +4% | +$83.5K |
|
|
MAZE
875
Maze Therapeutics
MAZE
$1.64B
| $2M | 0.01% |
48,200
-65,849
| -58% | -$2.26M |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.